MiR-155 has been reported to modulate viral infection by modulating host immune responses 66, and serum miR-155, as an inflammatory miRNA, has been shown to stimulate NF-κB activation and induce TNF-α and IL-6 production by delivery to macrophages 67. This evidence concerns the gene TNF and viral infectious disease.